From the ∗Department of Epidemiology, University of Washington, Seattle, WA
†Division of STD Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA
‡Department of Biostatistics, University of Washington
§Public Health–Seattle & King County, HIV/STD Program
¶Department of Medicine, University of Washington, Seattle, WA
Conflict of Interest and Sources of Funding: C.M.K. and M.R.G. have received specimen collection kits, reagents, and research support from Hologic, Inc for research studies unrelated to the submitted work. E.R. received funding support from the National Institutes of Health National Center for Advancing Translational Science (TR002318). The remaining authors declare no conflicts of interest.
Correspondence: Emily Rowlinson, PhD, MPH, University of Washington, Department of Epidemiology, UW Box # 351619, Seattle, WA 98195. E-mail: [email protected].
Received for publication June 14, 2022, and accepted October 5, 2022.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (http://www.stdjournal.com).
